ロード中...
Recurrent membranous nephropathy and acute cellular rejection in a patient treated with direct anti-HCV therapy (ledipasvir/sofosbuvir)
Direct-acting antiviral agents (DAAs) are very effective therapy for chronic hepatitis C infection, and have revolutionized the treatment of hepatitis C in kidney allograft recipients. Although well tolerated in general, rare renal complications have been reported. We describe a case of recurrent me...
保存先:
| 出版年: | Transpl Infect Dis |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6176715/ https://ncbi.nlm.nih.gov/pubmed/29968947 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/tid.12959 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|